Statewide

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

A new way of thinking about Alzheimer's disease has yielded a UVA research discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.

The Innovation Award honors breakthrough product development that significantly improves election verification and auditing. The program provides hands-on training and unmatched real-world experience.

The CCI awarded 18 seed grants to nine Virginia public universities for a total of $1.61M to address how artificial intelligence can make networks more secure, create new vulnerabilities, and more.

Luna Labs USA, LLC, a product development company accelerating breakthrough solutions will invest $200,000 to expand its operations in the City of Charlottesville. The company will create 20 new jobs.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.